{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:48Z","timestamp":1789524168993,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2017373"],"award-info":[{"award-number":["GNT2017373"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT209057 and GNT396414"],"award-info":[{"award-number":["GNT209057 and GNT396414"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1011618 and GNT1074383"],"award-info":[{"award-number":["GNT1011618 and GNT1074383"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2017373"],"award-info":[{"award-number":["GNT2017373"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF22025"],"award-info":[{"award-number":["MCRF22025"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumour DNA methylation is a potentially valuable marker of breast cancer survival, but previous studies have been limited by relatively small sample sizes. This study aimed to use a large sample size to identify survival-associated DNA methylation markers and develop a methylation-based signature predictive of breast cancer survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used DNA methylation data from 2,157 breast tumours collected in the Melbourne Collaborative Cohort Study (MCCS) and nine publicly available datasets. An epigenome-wide association study (EWAS) was conducted for five-year overall survival (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091,992 cases). Subgroup analyses were carried out by estrogen receptor status. Pathway enrichment analyses were conducted to identify related biological pathways. Elastic net Cox regression was used to develop a signature of survival from DNA methylation data and clinical characteristics, trained on publicly available datasets and tested in the MCCS (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009425) in addition to the main clinical characteristics. A set of triple-negative tumours (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009165) with disease-free survival as the outcome was used for additional replication.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 2,535 CpGs showing an association (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 1\u2009\u00d7\u200910\n                      <jats:sup>\u2212\u20097<\/jats:sup>\n                      ) with survival in age-adjusted models, including 281 after adjustment for estrogen receptor (ER) status. In ER-positive tumours, there were 389 associations, of which 315 were absent from the primary EWAS. A 228-CpG signature showed a strong association with survival in the MCCS after adjustment for clinical characteristics: per SD, HR\u2009=\u20091.7, 95%CI: 1.2\u20132.3,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001, with a C-index of 0.79, compared with a C-index of 0.75 without methylation information (C-index increase: 0.04, 95%CI: 0.01\u20130.10). The signature was also predictive of disease-free survival beyond clinical characteristics in triple-negative tumours (HR per SD\u2009=\u20091.4, 95% CI: 1.1\u20131.8).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings revealed numerous CpG sites where tumour DNA methylation was associated with breast cancer survival. A substantial improvement in the accuracy of five-year overall survival prediction was achieved by adding a 228-CpG epigenetic score to the main clinicopathological variables. These results suggest that DNA methylation markers may provide additional prognostic information beyond established clinicopathological factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02327-3","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:38:29Z","timestamp":1782473909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumour-based DNA methylation markers of breast cancer survival: a pooled analysis of 2157 cases"],"prefix":"10.1186","volume":"28","author":[{"given":"Elaheh","family":"Zarean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes","family":"Makalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham G.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Dugu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"3","key":"2327_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.semcancer.2009.02.007","volume":"19","author":"AM Dworkin","year":"2009","unstructured":"Dworkin AM, Huang TH, Toland AE. Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol. 2009;19(3):165\u201371.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"2327_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012\u201327.","journal-title":"Trends Genet"},{"issue":"9","key":"2327_CR3","doi-asserted-by":"publisher","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9):a019505.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"2327_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg AP, Koldobskiy MA, G\u00f6nd\u00f6r A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17(5):284\u201399.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2327_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrg1748","volume":"7","author":"AP Feinberg","year":"2006","unstructured":"Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet. 2006;7(1):21\u201333.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2327_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2021.5278","volume":"59","author":"MT Vietri","year":"2021","unstructured":"Vietri MT, D\u2019elia G, Benincasa G, Ferraro G, Caliendo G, Nicoletti GF, Napoli C. DNA methylation and breast cancer: a way forward. Int J Oncol. 2021;59(5):1\u201312.","journal-title":"Int J Oncol"},{"issue":"10","key":"2327_CR7","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajpath.2017.07.002","volume":"187","author":"V Davalos","year":"2017","unstructured":"Davalos V, Martinez-Cardus A, Esteller M. The epigenomic revolution in breast cancer: from single-gene to genome-wide next-generation approaches. Am J Pathol. 2017;187(10):2163\u201374.","journal-title":"Am J Pathol"},{"issue":"1","key":"2327_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12885-019-5403-0","volume":"19","author":"BP de Almeida","year":"2019","unstructured":"de Almeida BP, Apol\u00f3nio JD, Binnie A, Castelo-Branco P. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers. BMC Cancer. 2019;19(1):219.","journal-title":"BMC Cancer"},{"key":"2327_CR9","doi-asserted-by":"publisher","first-page":"1133443","DOI":"10.3389\/fgene.2023.1133443","volume":"14","author":"DH Kim","year":"2023","unstructured":"Kim DH, Binder AM, Zhou H, Jung SY. DNA methylation patterns associated with breast cancer prognosis that are specific to tumor subtype and menopausal status. Front Genet. 2023;14:1133443.","journal-title":"Front Genet"},{"issue":"16","key":"2327_CR10","doi-asserted-by":"publisher","first-page":"9378","DOI":"10.1111\/jcmm.15588","volume":"24","author":"Y Peng","year":"2020","unstructured":"Peng Y, Shui L, Xie J, Liu S. Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer. J Cell Mol Med. 2020;24(16):9378\u201387.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2327_CR11","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1002\/jcb.29461","volume":"121","author":"C Tao","year":"2020","unstructured":"Tao C, Luo R, Song J, Zhang W, Ran L. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer. J Cell Biochem. 2020;121(3):2385\u201393.","journal-title":"J Cell Biochem"},{"issue":"3","key":"2327_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-019-05417-3","volume":"178","author":"T Du","year":"2019","unstructured":"Du T, Liu B, Wang Z, Wan X, Wu Y. CpG methylation signature predicts prognosis in breast cancer. Breast Cancer Res Treat. 2019;178(3):565\u201372.","journal-title":"Breast Cancer Res Treat"},{"key":"2327_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fmolb.2020.00118","volume":"7","author":"XP Liu","year":"2020","unstructured":"Liu XP, Hou J, Chen C, Guan L, Hu HK, Li S. A DNA methylation-based panel for the prognosis and dagnosis of patients with breast cancer and its mechanisms. Front Mol Biosci. 2020;7:118.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2327_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13058-022-01537-9","volume":"24","author":"CA Pedersen","year":"2022","unstructured":"Pedersen CA, Cao MD, Fleischer T, Rye MB, Knappskog S, Eikesdal HP, L\u00f8nning PE, Tost J, Kristensen VN, Tessem M-B, et al. DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival. Breast Cancer Res. 2022;24(1):43.","journal-title":"Breast Cancer Res"},{"key":"2327_CR15","doi-asserted-by":"publisher","first-page":"e930025","DOI":"10.12659\/MSM.930025","volume":"27","author":"Y Gao","year":"2021","unstructured":"Gao Y, Wang X, Li S, Zhang Z, Li X, Lin F. Identification of a DNA methylation-based prognostic signature for patients with triple-negative breast cancer. Med Sci Monit. 2021;27:e930025.","journal-title":"Med Sci Monit"},{"key":"2327_CR16","doi-asserted-by":"publisher","first-page":"46290","DOI":"10.1038\/srep46290","volume":"7","author":"R Piazza","year":"2017","unstructured":"Piazza R, Ramazzotti D, Spinelli R, Pirola A, De Sano L, Ferrari P, Magistroni V, Cordani N, Sharma N, Gambacorti-Passerini C. OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes. Sci Rep. 2017;7:46290.","journal-title":"Sci Rep"},{"issue":"1","key":"2327_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13058-024-01955-x","volume":"27","author":"E Zarean","year":"2025","unstructured":"Zarean E, Li S, Wong EM, Makalic E, Milne RL, Giles GG, McLean C, Southey MC. Dugu\u00e9 P-A: Tumour DNA methylation markers associated with breast cancer survival: a replication study. Breast Cancer Res. 2025;27(1):9.","journal-title":"Breast Cancer Res"},{"issue":"28","key":"2327_CR18","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.1703577114","volume":"114","author":"X Hao","year":"2017","unstructured":"Hao X, Luo H, Krawczyk M, Wei W, Wang W, Wang J, Flagg K, Hou J, Zhang H, Yi S. DNA methylation markers for diagnosis and prognosis of common cancers. Proc Natl Acad Sci. 2017;114(28):7414\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"2327_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4314-9","volume":"18","author":"B Xiao","year":"2018","unstructured":"Xiao B, Chen L, Ke Y, Hang J, Cao L, Zhang R, Zhang W, Liao Y, Gao Y, Chen J. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer. BMC Cancer. 2018;18:1\u201313.","journal-title":"BMC Cancer"},{"issue":"2","key":"2327_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17501911.2024.2441653","volume":"17","author":"E Zarean","year":"2025","unstructured":"Zarean E, Li S, Wong EM, Makalic E, Milne RL, Giles GG, McLean C, Southey MC. Dugu\u00e9 P-A: Evaluation of agreement between common clustering strategies for DNA methylation-based subtyping of breast tumours. Epigenomics. 2025;17(2):105\u201314.","journal-title":"Epigenomics"},{"issue":"7418","key":"2327_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"CGA Network","year":"2012","unstructured":"Network CGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61.","journal-title":"Nature"},{"issue":"3","key":"2327_CR22","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/nar\/gkv907","volume":"44","author":"Z Xu","year":"2016","unstructured":"Xu Z, Niu L, Li L, Taylor JA. ENmix: a novel background correction method for Illumina HumanMethylation450 BeadChip. Nucleic Acids Res. 2016;44(3):e20\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2327_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13148-021-01207-1","volume":"13","author":"Z Xu","year":"2021","unstructured":"Xu Z, Niu L, Taylor JA. The ENmix DNA methylation analysis pipeline for Illumina BeadChip and comparisons with seven other preprocessing pipelines. Clin epigenetics. 2021;13(1):216.","journal-title":"Clin epigenetics"},{"issue":"1","key":"2327_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13059-022-02793-w","volume":"23","author":"AP Ori","year":"2022","unstructured":"Ori AP, Lu AT, Horvath S, Ophoff RA. Significant variation in the performance of DNA methylation predictors across data preprocessing and normalization strategies. Genome Biol. 2022;23(1):225.","journal-title":"Genome Biol"},{"issue":"2","key":"2327_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8(2):203\u20139.","journal-title":"Epigenetics"},{"key":"2327_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0569-x","volume":"16","author":"MC Benton","year":"2015","unstructured":"Benton MC, Johnstone A, Eccles D, Harmon B, Hayes MT, Lea RA, Griffiths L, Hoffman EP, Stubbs RS, Macartney-Coxson D. An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol. 2015;16:1\u201321.","journal-title":"Genome Biol"},{"issue":"4","key":"2327_CR27","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22.","journal-title":"Nucleic Acids Res"},{"key":"2327_CR28","unstructured":"Hastie T, Tibshirani R, Sherlock G, Eisen M, Brown P, Botstein D. Imputing missing data for gene expression arrays. 1999."},{"issue":"1","key":"2327_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2288-10-20","volume":"10","author":"CA Bellera","year":"2010","unstructured":"Bellera CA, MacGrogan G, Debled M, de Lara CT, Brouste V, Mathoulin-P\u00e9lissier S. Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC Med Res Methodol. 2010;10(1):20.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"2327_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","volume":"32","author":"B Phipson","year":"2016","unstructured":"Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform. Bioinformatics. 2016;32(2):286\u20138.","journal-title":"Bioinformatics"},{"key":"2327_CR31","doi-asserted-by":"crossref","unstructured":"Breiman L, Friedman J, Olshen RA, Stone CJ. Classification and regression trees: Routledge; 2017.","DOI":"10.1201\/9781315139470"},{"issue":"2","key":"2327_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Stat Soc Ser B: Stat Methodol. 2005;67(2):301\u201320.","journal-title":"J Royal Stat Soc Ser B: Stat Methodol"},{"issue":"3","key":"2327_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/10618600.2020.1714633","volume":"29","author":"B Efron","year":"2020","unstructured":"Efron B, Narasimhan B. The automatic construction of bootstrap confidence intervals. J Comput Graphical Stat. 2020;29(3):608\u201319.","journal-title":"J Comput Graphical Stat"},{"issue":"1","key":"2327_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2018.02.003","volume":"5","author":"Y Qin","year":"2018","unstructured":"Qin Y, Feng H, Chen M, Wu H, Zheng X. InfiniumPurify: An R package for estimating and accounting for tumor purity in cancer methylation research. Genes Dis. 2018;5(1):43\u20135.","journal-title":"Genes Dis"},{"key":"2327_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fmolb.2020.00118","volume":"7","author":"X-P Liu","year":"2020","unstructured":"Liu X-P, Hou J, Chen C, Guan L, Hu H-K, Li S. A DNA methylation-based panel for the prognosis and diagnosis of patients with breast cancer and its mechanisms. Front Mol Biosci. 2020;7:118.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"2327_CR36","first-page":"413","volume":"18","author":"P Jia","year":"2016","unstructured":"Jia P, Zhao Z. Impacts of somatic mutations on gene expression: an association perspective. Brief Bioinform. 2016;18(3):413\u201325.","journal-title":"Brief Bioinform"},{"issue":"1","key":"2327_CR37","first-page":"1","volume":"642","author":"C Sawan","year":"2008","unstructured":"Sawan C, Vaissi\u00e8re T, Murr R, Herceg Z. Epigenetic drivers and genetic passengers on the road to cancer. Mutat Res - Fundamental Mol Mech Mutagen. 2008;642(1):1\u201313.","journal-title":"Mutat Res - Fundamental Mol Mech Mutagen"},{"issue":"1","key":"2327_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2009","unstructured":"Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2009;31(1):27\u201336.","journal-title":"Carcinogenesis"},{"issue":"6","key":"2327_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s43018-022-00375-0","volume":"3","author":"KK Tsai","year":"2022","unstructured":"Tsai KK, Huang SS, Northey JJ, Liao WY, Hsu CC, Cheng LH, Werner ME, Chuu CP, Chatterjee C, Lakins JN, et al. Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity. Nat Cancer. 2022;3(6):734\u201352.","journal-title":"Nat Cancer"},{"key":"2327_CR40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3389\/fonc.2019.01279","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Chen X, Gong Z, Zhang H, Fei F, Tang X, Wang J, Xu P, Zarbl H, Ren X. Fry is required for mammary gland development during pregnant periods and affects the morphology and growth of breast cancer cells. Front Oncol. 2019;9:1279.","journal-title":"Front Oncol"},{"issue":"6","key":"2327_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ajhg.2024.04.012","volume":"111","author":"ST Head","year":"2024","unstructured":"Head ST, Dezem F, Todor A, Yang J, Plummer J, Gayther S, Kar S, Schildkraut J, Epstein MP. Cis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia. Am J Hum Genet. 2024;111(6):1084\u201399.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2327_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12014-015-9080-y","volume":"12","author":"HJ Johansson","year":"2015","unstructured":"Johansson HJ, Sanchez BC, Forshed J, St\u00e5l O, Fohlin H, Lewensohn R, Hall P, Bergh J, Lehti\u00f6 J, Linderholm BK. Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer. Clin Proteomics. 2015;12(1):8.","journal-title":"Clin Proteomics"},{"issue":"11","key":"2327_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/gcc.22279","volume":"54","author":"J Kim","year":"2015","unstructured":"Kim J, Kim S, Ko S, In YH, Moon HG, Ahn SK, Kim MK, Lee M, Hwang JH, Ju YS, et al. Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples. Genes Chromosomes Cancer. 2015;54(11):681\u201391.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2327_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13058-020-1250-9","volume":"22","author":"TC de Ruijter","year":"2020","unstructured":"de Ruijter TC, van der Heide F, Smits KM, Aarts MJ, van Engeland M, Heijnen VCG. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review. Breast Cancer Res. 2020;22(1):13.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2327_CR45","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3892\/mco.2015.620","volume":"3","author":"T Guo","year":"2015","unstructured":"Guo T, Ren Y, Wang B, Huang Y, Jia S, Tang W, Luo Y. Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptor\u2013negative tumors and the prognosis of breast cancer: A meta-analysis. Mol Clin Oncol. 2015;3(6):1353\u201360.","journal-title":"Mol Clin Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02327-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02327-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02327-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:36:04Z","timestamp":1789522564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02327-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2327"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02327-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8023797\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Human Research Ethics Committee of Cancer Council Victoria. Informed consent was obtained from all subjects involved in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of the manuscript and consent to its publication in this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"155"}}